retatrutide regulatory status clinical trial approval: FDA status, results, and when it could be available Triple hormone receptor agonist retatrutide – Triple hormone receptor agonist retatrutide – We get asked about this

Step 3 Coaching & FollowUps

*Correspondence: Li Luo, [email protected]

Several factors may explain why patients report hot flushes whilst taking Ozempic: Metabolic changes : Significant weight loss and alterations in body composition can affect thermoregulation Hormonal fluctuations : Weight loss may influence sex hormone levels, particularly oestrogen Blood glucose variations : Rapid changes in glycaemic control may trigger autonomic responses Concurrent medications or conditions : Many patients with type 2 diabetes take multiple medications that could contribute to vasomotor symptoms There is no official link established between Ozempic and hot flushes based on current evidence from randomised controlled trials

(October 2014)

Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, Kashyap S, Mechanick JI, Mouzaki M, Nadolsky K, Rinella ME, Vos MB, Younossi Z